Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FysioDanmark Horsens ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   10.1% 12.4% 6.3% 12.2% 8.7% 7.2% 15.8% 15.4%   Credit score (0-100)   25 19 36 18 27 33 12 13   Credit rating   BB BB BBB BB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   7,069 6,972 8,369 7,581 9,164 9,077 0.0 0.0   EBITDA   1,366 883 1,348 372 1,141 1,314 0.0 0.0   EBIT   1,088 617 1,089 134 903 1,091 0.0 0.0   Pre-tax profit (PTP)   927.0 524.0 1,052.7 81.5 870.4 1,060.3 0.0 0.0   Net earnings   819.0 405.0 819.5 59.0 676.3 823.2 0.0 0.0   Pre-tax profit without non-rec. items   927 524 1,053 81.5 870 1,060 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   246 180 121 83.2 45.1 22.3 0.0 0.0   Shareholders equity total   -637 -232 587 121 798 874 1.9 1.9   Interest-bearing liabilities   2,458 536 0.0 539 635 339 198 198   Balance sheet total (assets)   3,354 2,678 2,840 2,357 2,943 2,494 200 200   Net Debt   2,444 533 -487 425 -437 -630 198 198     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   7,069 6,972 8,369 7,581 9,164 9,077 0.0 0.0   Gross profit growth   12.3% -1.4% 20.0% -9.4% 20.9% -1.0% -100.0% 0.0%   Employees   15 14 16 16 18 17 0 0   Employee growth %   7.1% -6.7% 14.3% 0.0% 12.5% -5.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,354 2,678 2,840 2,357 2,943 2,494 200 200   Balance sheet change%   3.1% -20.2% 6.1% -17.0% 24.8% -15.3% -92.0% 0.0%   Added value   1,366.0 883.0 1,347.9 372.5 1,141.1 1,313.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -499 -532 -517 -476 -476 -445 -22 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.4% 8.8% 13.0% 1.8% 9.9% 12.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.2% 18.1% 38.1% 5.2% 34.5% 40.4% 0.0% 0.0%   ROI %   32.4% 26.4% 70.0% 11.2% 80.0% 80.0% 0.0% 0.0%   ROE %   24.8% 13.4% 50.2% 16.7% 147.2% 98.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -16.0% -8.0% 20.7% 5.2% 27.3% 35.5% 1.0% 1.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   178.9% 60.4% -36.1% 114.1% -38.3% -48.0% 0.0% 0.0%   Gearing %   -385.9% -231.0% 0.0% 443.8% 79.6% 38.8% 10,273.4% 10,273.4%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.5% 6.7% 16.1% 20.2% 7.3% 8.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.9 0.5 1.1 0.9 1.1 1.4 0.0 0.0   Current Ratio   0.9 0.5 1.2 1.0 1.1 1.4 0.0 0.0   Cash and cash equivalent   14.0 3.0 486.9 113.8 1,071.6 969.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -113.0 -944.0 191.8 -34.5 226.4 548.2 -99.0 -99.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   91 63 84 23 63 77 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   91 63 84 23 63 77 0 0   EBIT / employee   73 44 68 8 50 64 0 0   Net earnings / employee   55 29 51 4 38 48 0 0